Reuters logo
BRIEF-Bayer receives approval for Nexavar in Japan for treatment of thyroid cancer
June 20, 2014 / 6:37 AM / 3 years ago

BRIEF-Bayer receives approval for Nexavar in Japan for treatment of thyroid cancer

June 20 (Reuters) - Bayer AG : * Says receives approval for Nexavar (sorafenib) in Japan for treatment of

differentiated thyroid cancer

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below